Do NOT Give Dexophen to Children Under 2 Years Old
Dexophen and similar over-the-counter cough and cold medications containing dextromethorphan, phenylephrine, chlorpheniramine, and/or pseudoephedrine should NOT be used in children under 4 years of age, and are particularly dangerous in those under 2 years. This recommendation is based on FDA warnings, manufacturer relabeling, and evidence of serious morbidity and mortality in young children 1.
Why This Is Dangerous
Lack of Efficacy
- OTC cough medications have little to no benefit in controlling cough symptoms in young children 1
- There is no evidence these medications make cough less severe or resolve sooner in this age group 1
- The individual components (antihistamines, dextromethorphan, decongestants) show minimal to no efficacy in pediatric populations 1
Serious Safety Concerns
Documented mortality and morbidity:
- Reported deaths from toxicity in young children, including infants 1, 2
- Fatal intoxications documented with pseudoephedrine, brompheniramine, and dextromethorphan combinations 2
- Adverse events specifically associated with preparations containing antihistamines and dextromethorphan 1, 3
Specific risks from each component:
- Dextromethorphan: CNS side effects including hyperexcitability, increased muscle tone, ataxia, and deaths with overdose 4
- Pseudoephedrine/Phenylephrine: Cardiovascular effects, nervousness, potentially life-threatening adverse effects 5, 6
- Chlorpheniramine: Sedation and anticholinergic effects in young children 1
Regulatory Actions
- FDA issued warnings against using OTC cough/cold medications in young children following the 2006 CHEST guidelines 1
- Manufacturers voluntarily relabeled products: "do not use in children under 4 years of age" 1
- FDA drug labels explicitly state "children under 4 years of age: do not use" 7
What to Use Instead
For children under 2 years with cough:
- Honey (for children ≥12 months): May offer more relief than no treatment, diphenhydramine, or placebo 1
- Supportive care: Hydration, humidification, nasal saline
- Treat the underlying cause: Most childhood cough is from expected respiratory infections that resolve spontaneously 1
Critical Pitfalls to Avoid
- Accidental overdose: Most serious adverse events occur from accidental unsupervised ingestions, with 96% involving dextromethorphan and diphenhydramine 3
- Parental dosing errors: Studies show 76% of mothers administered double the recommended dose 8
- Multiple product use: Parents may unknowingly give multiple products containing the same ingredients
- Assuming "over-the-counter = safe": Widespread availability does not equal safety in young children 8
The risk-benefit ratio is unequivocally unfavorable: no proven benefit with documented risk of serious harm including death.